Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Pelegrin

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Drug News & Perspectives|November 27, 2008
Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1Pablo Pelegrin
Biochemical Pharmacology|December 28, 2020
P2X7 receptor and the NLRP3 inflammasome: Partners in crimePablo Pelegrin
The Journal of Biological Chemistry|November 24, 2006
Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathwayPablo Pelegrin, Annmarie Surprenant
EMBO Molecular Medicine|May 16, 2022
ASC nanobodies to counteract the consequences of inflammasome activationSahil Adriouch, Pablo Pelegrin
The EMBO Journal|October 13, 2006
Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptorPablo Pelegrin, Annmarie Surprenant
Trends in Cell Biology|October 4, 2020
Cardiolipin in Immune Signaling and Cell DeathMalvina Pizzuto, Pablo Pelegrin
Purinergic Signalling|February 13, 2009
The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta releasePablo Pelegrin, Annmarie Surprenant
The EMBO Journal|June 19, 2009
Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphatesPablo Pelegrin, Annmarie Surprenant
Expert Opinion on Investigational Drugs|May 31, 2011
P2X7 receptor antagonism in the treatment of cancersSébastien Roger, Pablo Pelegrin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 20, 2008
Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin bindingSébastien Roger, Pablo Pelegrin, Annmarie Surprenant
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Drug News & Perspectives|November 27, 2008
Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1Pablo Pelegrin
Biochemical Pharmacology|December 28, 2020
P2X7 receptor and the NLRP3 inflammasome: Partners in crimePablo Pelegrin
The Journal of Biological Chemistry|November 24, 2006
Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathwayPablo Pelegrin, Annmarie Surprenant
EMBO Molecular Medicine|May 16, 2022
ASC nanobodies to counteract the consequences of inflammasome activationSahil Adriouch, Pablo Pelegrin
The EMBO Journal|October 13, 2006
Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptorPablo Pelegrin, Annmarie Surprenant
Trends in Cell Biology|October 4, 2020
Cardiolipin in Immune Signaling and Cell DeathMalvina Pizzuto, Pablo Pelegrin
Purinergic Signalling|February 13, 2009
The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta releasePablo Pelegrin, Annmarie Surprenant
The EMBO Journal|June 19, 2009
Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphatesPablo Pelegrin, Annmarie Surprenant
Expert Opinion on Investigational Drugs|May 31, 2011
P2X7 receptor antagonism in the treatment of cancersSébastien Roger, Pablo Pelegrin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 20, 2008
Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin bindingSébastien Roger, Pablo Pelegrin, Annmarie Surprenant
Pageof 6